{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:54:02Z","timestamp":1788000842314,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/aps.2016.145","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T10:06:19Z","timestamp":1485165979000},"page":"477-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hippocampal CysLT1R knockdown or blockade represses LPS-induced depressive behaviors and neuroinflammatory response in mice"],"prefix":"10.1038","volume":"38","author":[{"given":"Jing-ran","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-chang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-su","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-yi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"key":"BFaps2016145_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/35072566","volume":"2","author":"ML Wong","year":"2001","unstructured":"Wong ML, Licinio J . Research and treatment approaches to depression. Nat Rev Neurosci 2001; 2: 343\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"BFaps2016145_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2165\/11530280-000000000-00000","volume":"24","author":"RC Shelton","year":"2010","unstructured":"Shelton RC, Osuntokun O, Heinloth AN, Corya SA . Therapeutic options for treatment-resistant depression. CNS Drugs 2010; 24: 131\u201361.","journal-title":"CNS Drugs"},{"key":"BFaps2016145_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/070674371005500205","volume":"55","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager WL, Reim EK, Lanct\u00f4t KL . Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Can J Psychiatry 2010; 55: 91\u20139.","journal-title":"Can J Psychiatry"},{"key":"BFaps2016145_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1006\/cyto.1999.0661","volume":"12","author":"TA Babcock","year":"2000","unstructured":"Babcock TA, Carlin JM . Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 2000; 12: 588\u201394.","journal-title":"Cytokine"},{"key":"BFaps2016145_CR5","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, Dellagioia N, Bloch M . The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011; 36: 2452\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"BFaps2016145_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2003.11.004","volume":"18","author":"L Capuron","year":"2004","unstructured":"Capuron L, Ravaud A, Miller AH, Dantzer R . Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and\/or interferon-alpha cancer therapy. Brain Behav Immun 2004; 18: 205\u201313.","journal-title":"Brain Behav Immun"},{"key":"BFaps2016145_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","volume":"62","author":"MP Kaster","year":"2012","unstructured":"Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL . Depressive-like behavior induced by tumor necrosis factor-\u03b1 in mice. Neuropharmacology 2012; 62: 419\u201326.","journal-title":"Neuropharmacology"},{"key":"BFaps2016145_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jpsychires.2013.06.008","volume":"47","author":"BS Mello","year":"2013","unstructured":"Mello BS, Monte AS, Mcintyre RS, Soczynska JK, Cust\u00f3dio CS, Cordeiro RC, et al. Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J Psychiatr Res 2013; 47: 1521\u20139.","journal-title":"J Psychiatr Res"},{"key":"BFaps2016145_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbr.2010.07.015","volume":"215","author":"VN De Paiva","year":"2010","unstructured":"De Paiva VN, Lima SN, Fernandes MM, Soncini R, Andrade CA, Giusti-Paiva A . Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav Brain Res 2010; 215: 146\u201351.","journal-title":"Behav Brain Res"},{"key":"BFaps2016145_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000312669","volume":"85","author":"RK Singh","year":"2010","unstructured":"Singh RK, Gupta S, Dastidar S, Ray A . Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 2010; 85: 336\u201349.","journal-title":"Pharmacology"},{"key":"BFaps2016145_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s10787-007-1585-1","volume":"15","author":"H Nishio","year":"2008","unstructured":"Nishio H, Hayashi Y, Terashima S, Takeuchi K . Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats. Inflammopharmacology 2008; 15: 266\u201372.","journal-title":"Inflammopharmacology"},{"key":"BFaps2016145_CR12","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1124\/jpet.106.115436","volume":"321","author":"NL Rao","year":"2007","unstructured":"Rao NL, Dunford PJ, Xue X, Jiang X, Lundeen KA, Coles F, et al. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther 2007; 321: 1154\u201360.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps2016145_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.pupt.2007.05.003","volume":"21","author":"V Schelfhout","year":"2008","unstructured":"Schelfhout V, Van De Velde V, Pauwels R, Joos G . The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma \u2014 A comparison with leukotriene D4 induced broncoconstriction. Pulm Pharmacol Ther 2008; 21: 276\u201384.","journal-title":"Pulm Pharmacol Ther"},{"key":"BFaps2016145_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1017\/S1461145713001314","volume":"17","author":"SS Tang","year":"2014","unstructured":"Tang SS, Ji MJ, Chen L, Hu M, Long Y, Li YQ, et al. Protective effect of pranlukast on A\u03b21-42-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1. Int J Neuropsychopharmacol 2014; 17: 581\u201392.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFaps2016145_CR15","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/j.1745-7254.2006.00458.x","volume":"27","author":"YJ Zhang","year":"2006","unstructured":"Zhang YJ, Zhang L, Ye YL, Fang SH, Zhou Y, Zhang WP, et al. Cysteinyl leukotriene receptors CysLT1 and CysLT2 are upregulated in acute neuronal injury after focal cerebral ischemia in mice. Acta Pharmacol Sin 2006; 27: 1553\u201360.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2016145_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neulet.2004.03.088","volume":"363","author":"WP Zhang","year":"2004","unstructured":"Zhang WP, Hu H, Zhang L, Ding W, Yao HT, Chen KD, et al. Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neurosci Lett 2004; 363: 247\u201351.","journal-title":"Neurosci Lett"},{"key":"BFaps2016145_CR17","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.4049\/jimmunol.1100333","volume":"187","author":"L Wang","year":"2011","unstructured":"Wang L, Du C, Lv J, Wei W, Cui Y, Xie X . Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 2011; 187: 2336\u201345.","journal-title":"J Immunol"},{"key":"BFaps2016145_CR18","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s00213-015-4136-2","volume":"233","author":"XB Yu","year":"2016","unstructured":"Yu XB, Dong RR, Wang H, Lin JR, An YQ, Du Y, et al. Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice. Psychopharmacology (Berl) 2016; 233: 1739\u201349.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFaps2016145_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuron.2012.12.038","volume":"77","author":"MA Kheirbek","year":"2013","unstructured":"Kheirbek MA, Drew LJ, Burqhardt NS, Costantini DO, Tannenholz L, Ahmari SE, et al. Differential control of learning and anxiety along the dorsalventral axis of the dentate gyrus. Neuron 2013; 77: 955\u201368.","journal-title":"Neuron"},{"key":"BFaps2016145_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Stephanie D, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805\u20139.","journal-title":"Science"},{"key":"BFaps2016145_CR21","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M . Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327\u201336.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BFaps2016145_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Mombereau C, Vassout A . The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005; 29: 571\u2013625.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFaps2016145_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000199724","volume":"149","author":"K Hashimoto","year":"2009","unstructured":"Hashimoto K, Ichiyama T, Hasegawa M, Hasegawa S, Matsubara T, Furukawa S . Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte\/macrophages via mitogen-activated protein kinase and nuclear factor-\u03baB pathways. Int Arch Allergy Immunol 2009; 149: 275\u201382.","journal-title":"Int Arch Allergy Immunol"},{"key":"BFaps2016145_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Lawson MA, Andr\u00e9 C, Moreau M, Lestage J, Castanon N, et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009; 14: 511\u201322.","journal-title":"Mol Psychiatry"},{"key":"BFaps2016145_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.neuint.2013.01.002","volume":"62","author":"XY Wang","year":"2013","unstructured":"Wang XY, Tang SS, Hu M, Long Y, Li YQ, Liao MX, et al. Leukotriene D4 induces amyloid-\u03b2 generation via CysLT(1)R-mediated NF-\u03baB pathways in primary neurons. Neurochem Int 2013, 62: 340\u20137.","journal-title":"Neurochem Int"},{"key":"BFaps2016145_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1067\/mai.2003.1636","volume":"112","author":"T Kawano","year":"2003","unstructured":"Kawano T, Matsuse H, Kondo Y, Machida I, Saeki S, Tomari S, et al. Cysteinyl leukotrienes induce nuclear factor kappaB activation and rantes production in a murine model of asthma. J Allergy Clin Immunol 2003; 112: 369\u201374.","journal-title":"J Allergy Clin Immunol"},{"key":"BFaps2016145_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","volume":"29","author":"FV Santa-Cec\u00edlia","year":"2016","unstructured":"Santa-Cec\u00edlia FV, Socias B, Ouidja MO, Sepulveda-Diaz JE, Acu\u00f1a L, Silva RL, et al. Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-\u03baB signaling pathways. Neurotox Res 2016; 29: 447\u201359.","journal-title":"Neurotox Res"},{"key":"BFaps2016145_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","volume":"119","author":"MB Graeber","year":"2010","unstructured":"Graeber MB, Streit WJ . Microglia: biology and pathology. Acta Neuropathol 2010; 119: 89\u2013105.","journal-title":"Acta Neuropathol"},{"key":"BFaps2016145_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/jnnp-2011-301779","volume":"83","author":"R Krishnadas","year":"2012","unstructured":"Krishnadas R, Cavanagh J . Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry 2012; 83: 495\u2013502.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFaps2016145_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/475027a","volume":"475","author":"PY Collins","year":"2011","unstructured":"Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, et al. Grand challenges in global mental health. Nature 2011; 475: 27\u201330.","journal-title":"Nature"},{"issue":"12","key":"BFaps2016145_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/cns.12596","volume":"22","author":"Arijit Ghosh","year":"2016","unstructured":"Ghosh A, Chen F, Thakur A, Hong H . Cysteinyl leukotrienes and their receptors: emerging therapeutic targets in central nervous system disorders. CNS Neurosci Ther 2016. doi:10.1111\/cns.12596.","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"BFaps2016145_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/aps.2016.63","volume":"37","author":"JQ Zhang","year":"2016","unstructured":"Zhang JQ, Wu XH, Feng Y, Xie XF, Fan YH, Yan S, et al. Salvianolic acid B ameliorates depressive-like behaviors in chronic mild stress-treated mice: involvement of the neuroinflammatory pathway. Acta Pharmacol Sin 2016; 37: 1141\u201353.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2016145_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW . From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"BFaps2016145_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart BL . Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988; 12: 123\u201337.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFaps2016145_CR35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.pbb.2005.04.019","volume":"81","author":"AJ Dunn","year":"2005","unstructured":"Dunn AJ, Swiergiel AH . Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav 2005; 81: 688\u201393.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFaps2016145_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-5-15","volume":"5","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 2008; 5: 15.","journal-title":"J Neuroinflammation"},{"key":"BFaps2016145_CR37","doi-asserted-by":"publisher","first-page":"pyu077","DOI":"10.1093\/ijnp\/pyu077","volume":"18","author":"JC Zhang","year":"2014","unstructured":"Zhang JC, Wu J, Fujita Y, Yao W, Ren Q, Yang C, et al. Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation. Int J Neuropsychopharmacol 2014; 18. pii: pyu077. doi:10.1093\/ijnp\/pyu077.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFaps2016145_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neuroscience.2014.03.025","volume":"268","author":"VS Tomaz","year":"2014","unstructured":"Tomaz VS, Cordeiro RC, Costa AM, de Lucena DF, Nobre J\u00fanior HV, de Sousa FC, et al. Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice. Neuroscience 2014; 268: 236\u201346.","journal-title":"Neuroscience"},{"key":"BFaps2016145_CR39","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/0269881108091077","volume":"23","author":"T Eller","year":"2008","unstructured":"Eller T, Vasar V, Shlik J, Maron E . Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder. J Psychopharmacol 2008; 23: 854\u20138.","journal-title":"J Psychopharmacol"},{"key":"BFaps2016145_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","volume":"139","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ho CM, Mak A . Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 2012; 139: 230\u20139.","journal-title":"J Affect Disord"},{"key":"BFaps2016145_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3181\/0707-MR-196","volume":"233","author":"G Sethi","year":"2008","unstructured":"Sethi G, Sung B, Aggarwal BB . Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 2008; 233: 21\u201331.","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFaps2016145_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1745-7254.2008.00751.x","volume":"29","author":"L Qiao","year":"2008","unstructured":"Qiao L, Zhao TJ, Wang FZ, Shan CL, Ye LH, Zhang XD . NF-kappaB downregulation may be involved in the depression of tumor cell proliferation mediated by human mesenchymal stem cells. Acta Pharmacol Sin 2008; 29: 333\u201340.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps2016145_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000112866","volume":"81","author":"S Suzuki","year":"2008","unstructured":"Suzuki S, Takeuchi K, Ishinaga H, Basbaum C, Majima Y . Leukotriene D4 upregulates MUC2 gene transcription in human epithelial cells. Pharmacology 2008; 81: 221\u20138.","journal-title":"Pharmacology"},{"key":"BFaps2016145_CR44","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1165\/rcmb.2005-0407OC","volume":"35","author":"C Thompson","year":"2006","unstructured":"Thompson C, Cloutier A, Boss\u00e9 Y, Thivierge M, Gouill CL, Lariv\u00e9e P, et al. CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression. Am J Respir Cell Mol Biol 2006; 35: 697\u2013704.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFaps2016145_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007; 55: 453\u201362.","journal-title":"Glia"},{"key":"BFaps2016145_CR46","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.1038\/ncomms9466","volume":"6","author":"J Marschallinger","year":"2015","unstructured":"Marschallinger J, Sch\u00e4ffner I, Klein B, Gelfert R, Rivera FJ, Illes S, et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nat Commun 2015; 6: 8466.","journal-title":"Nat Commun"},{"key":"BFaps2016145_CR47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/cns.12116","volume":"19","author":"Y Song","year":"2013","unstructured":"Song Y, Chen X, Wang LY, Gao W, Zhu MJ . Rho kinase inhibitor fasudil protects against \u03b2-amyloid-induced hippocampal neurodegeneration in rats. CNS Neurosci Ther 2013; 19: 603\u201310.","journal-title":"CNS Neurosci Ther"},{"key":"BFaps2016145_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0165-5728(01)00316-2","volume":"117","author":"SM Ye","year":"2001","unstructured":"Ye SM, Johnson RW . Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappaB. J Neuroimmunol 2001; 117: 87\u201396.","journal-title":"J Neuroimmunol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2016145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2016145","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2016145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:34:03Z","timestamp":1684413243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2016145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFaps2016145"],"URL":"https:\/\/doi.org\/10.1038\/aps.2016.145","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]},"assertion":[{"value":"11 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}